Ahmed M. Bayoumi




Dr. Ahmed Bayoumi is a Scientist at MAP Centre for Urban Health Solutions at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, where he is also a general internist and Human Immunodeficiency Virus (HIV) physician. He holds the Fondation Baxter and Alma Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto and is a Professor in the Department of Medicine and in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a Senior Adjunct Scientist at ICES. He has extensive experience in translating research to policy (member of the Canadian Drug Expert Committee, past Scientific Director of Converge3, past president of the international Society for Medical Decision Making, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto). He has co-led large multi-method studies, including the highly impactful Toronto and Ottawa Supervised Consumption Assessment (TOSCA) and the Marginalization and COVID-19 (MARCO) studies. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations. He is a member of HMRAC (the Homelessness, Mortality, Research and Advocacy Coalition), an academic – community collaboration that meets regularly to discuss how research can address issues related to homelessness.

Recent Publications

  1. Long, C, Guimond, T, Bayoumi, AM, Firestone, M, Strike, C. The multiple makings of a supervised consumption service in a hospital setting. Int J Drug Policy. 2023;123 :104260. doi: 10.1016/j.drugpo.2023.104260. PubMed PMID:38035448 .
  2. Ali, F, Russell, C, Kaura, A, Leslie, P, Bayoumi, AM, Hopkins, S et al.. Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study. PLoS One. 2023;18 (10):e0292862. doi: 10.1371/journal.pone.0292862. PubMed PMID:37844109 PubMed Central PMC10578573.
  3. Schmidt, RA, Kaminski, N, Kryszajtys, DT, Rudzinski, K, Perri, M, Guta, A et al.. 'I don't chase drugs as much anymore, and I'm not dead': Client reported outcomes associated with safer opioid supply programs in Ontario, Canada. Drug Alcohol Rev. 2023;42 (7):1825-1837. doi: 10.1111/dar.13745. PubMed PMID:37718646 .
  4. Jiancaro, T, Bayoumi, AM, Ibáñez-Carrasco, F, Torres, B, McDuff, K, Brown, DA et al.. Factors influencing initial implementation of an online community-based exercise intervention with adults living with HIV: a systems approach. Front Rehabil Sci. 2023;4 :1176960. doi: 10.3389/fresc.2023.1176960. PubMed PMID:37546578 PubMed Central PMC10399961.
  5. Mahmoud Refaie, MM, Bayoumi, AM, Mokhemer, SA, Shehata, S, Abd El-Hameed, NM. Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity. Hum Exp Toxicol. 2023;42 :9603271231193392. doi: 10.1177/09603271231193392. PubMed PMID:37526264 .
  6. Leung, KHB, Yousefi, N, Chan, TCY, Bayoumi, AM. Constrained Optimization for Decision Making in Health Care Using Python: A Tutorial. Med Decis Making. 2023;43 (7-8):760-773. doi: 10.1177/0272989X231188027. PubMed PMID:37480282 PubMed Central PMC10625722.
  7. Ahmed, AF, Sharkawi, SS, AbdelHameed, SS, Bayoumi, AM, Moussa, RS, Alhakamy, NA et al.. Corrigendum to "Ketogenic diet restores hormonal, apoptotic/proliferative balance and enhances the effect of metformin on a letrozole-induced polycystic ovary model in rats" [Life Sci. 313 (2022) 121285]. Life Sci. 2023;326 :121829. doi: 10.1016/j.lfs.2023.121829. PubMed PMID:37271624 .
  8. Mahmoud Refaie, MM, Ahmed Rifaai, R, Bayoumi, AMA, Shehata, S. Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways. J Pharm Pharmacol. 2023;75 (9):1237-1248. doi: 10.1093/jpp/rgad049. PubMed PMID:37262315 .
  9. Bayoumi, AMA, Ismail, MAM, Mahmoud, SS, Soliman, ASA, Mousa, AMA, Yousof, HSA et al.. The potential curative and hepatoprotective effects of platelet rich plasma on liver fibrosis in Schistosoma mansoni experimentally infected mice. J Parasit Dis. 2023;47 (2):349-362. doi: 10.1007/s12639-023-01576-9. PubMed PMID:37193508 PubMed Central PMC10182195.
  10. Bayoumi, AM. Quantitative Assessment of Parent and Patient Preferences. JAMA Netw Open. 2023;6 (5):e2313509. doi: 10.1001/jamanetworkopen.2023.13509. PubMed PMID:37184841 .
Search PubMed

Affiliations & Other Activities

  • Scientist, MAP Centre for Urban Health Solutions, St. Michael’s Hospital
  • Professor, Department of Medicine, University of Toronto
  • Professor, Institute of Health Policy, Management and Evaluation, University of Toronto